Maggie Stanislawski
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastrointestinal Microbiome | 8 | 2023 | 561 | 2.450 |
Why?
| Microbiota | 8 | 2023 | 676 | 1.930 |
Why?
| Obesity | 7 | 2023 | 2786 | 1.020 |
Why?
| United States Department of Veterans Affairs | 14 | 2020 | 564 | 0.880 |
Why?
| Body Mass Index | 6 | 2020 | 2144 | 0.860 |
Why?
| Behavior Therapy | 2 | 2021 | 249 | 0.850 |
Why?
| Percutaneous Coronary Intervention | 11 | 2020 | 535 | 0.820 |
Why?
| Fatty Liver | 2 | 2021 | 254 | 0.770 |
Why?
| Lipopolysaccharide Receptors | 1 | 2021 | 89 | 0.770 |
Why?
| Weight Loss | 2 | 2021 | 663 | 0.720 |
Why?
| Inflammatory Bowel Diseases | 1 | 2023 | 290 | 0.700 |
Why?
| Biostatistics | 1 | 2018 | 18 | 0.650 |
Why?
| Weight Gain | 2 | 2018 | 511 | 0.610 |
Why?
| Pacemaker, Artificial | 4 | 2020 | 116 | 0.600 |
Why?
| Coronary Artery Disease | 6 | 2023 | 695 | 0.600 |
Why?
| Gastrointestinal Tract | 1 | 2019 | 176 | 0.580 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2021 | 2127 | 0.560 |
Why?
| Bacteria | 3 | 2020 | 772 | 0.550 |
Why?
| Phylogeny | 2 | 2018 | 830 | 0.540 |
Why?
| Insulin Resistance | 2 | 2021 | 1192 | 0.530 |
Why?
| Prosthesis-Related Infections | 4 | 2020 | 74 | 0.510 |
Why?
| Pediatric Obesity | 2 | 2019 | 541 | 0.510 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 284 | 0.500 |
Why?
| Antibiotic Prophylaxis | 3 | 2020 | 101 | 0.490 |
Why?
| Feces | 4 | 2021 | 410 | 0.470 |
Why?
| RNA, Ribosomal, 16S | 5 | 2018 | 535 | 0.470 |
Why?
| Liver | 2 | 2020 | 1827 | 0.460 |
Why?
| Veterans Health | 4 | 2018 | 167 | 0.460 |
Why?
| Phenotype | 4 | 2023 | 3070 | 0.450 |
Why?
| Risk Factors | 15 | 2023 | 9381 | 0.410 |
Why?
| Coronary Artery Bypass | 4 | 2017 | 226 | 0.400 |
Why?
| Pregnancy | 4 | 2021 | 5854 | 0.380 |
Why?
| Female | 35 | 2023 | 63629 | 0.370 |
Why?
| Veterans | 7 | 2018 | 1203 | 0.360 |
Why?
| Humans | 43 | 2023 | 122796 | 0.350 |
Why?
| Cardiovascular Diseases | 1 | 2021 | 1859 | 0.340 |
Why?
| Male | 31 | 2023 | 59639 | 0.340 |
Why?
| Middle Aged | 26 | 2023 | 28563 | 0.320 |
Why?
| Bifidobacterium | 2 | 2017 | 23 | 0.320 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2021 | 2221 | 0.310 |
Why?
| Myocardial Infarction | 6 | 2018 | 1134 | 0.300 |
Why?
| Coronary Angiography | 7 | 2020 | 336 | 0.290 |
Why?
| Anti-Infective Agents | 2 | 2020 | 248 | 0.260 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 459 | 0.260 |
Why?
| Aged | 21 | 2021 | 20495 | 0.260 |
Why?
| Radial Artery | 2 | 2017 | 81 | 0.250 |
Why?
| Time Factors | 10 | 2021 | 6682 | 0.250 |
Why?
| Diet | 3 | 2023 | 1168 | 0.240 |
Why?
| Child | 6 | 2021 | 19561 | 0.240 |
Why?
| Defibrillators, Implantable | 2 | 2020 | 397 | 0.240 |
Why?
| United States | 20 | 2020 | 13272 | 0.230 |
Why?
| Risk Assessment | 4 | 2021 | 3213 | 0.230 |
Why?
| Registries | 3 | 2019 | 2020 | 0.230 |
Why?
| Electronic Health Records | 2 | 2020 | 842 | 0.220 |
Why?
| Metagenomics | 1 | 2023 | 144 | 0.220 |
Why?
| Age Factors | 2 | 2021 | 3114 | 0.210 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 602 | 0.210 |
Why?
| Norway | 2 | 2018 | 37 | 0.210 |
Why?
| Patient Identification Systems | 2 | 2019 | 20 | 0.210 |
Why?
| Acute Kidney Injury | 2 | 2020 | 755 | 0.210 |
Why?
| Mothers | 2 | 2018 | 728 | 0.210 |
Why?
| Mississippi | 1 | 2021 | 19 | 0.200 |
Why?
| Diet, Reducing | 1 | 2021 | 82 | 0.200 |
Why?
| Waist Circumference | 1 | 2021 | 132 | 0.200 |
Why?
| Incidence | 4 | 2021 | 2527 | 0.200 |
Why?
| Caloric Restriction | 1 | 2021 | 91 | 0.190 |
Why?
| Gardening | 1 | 2020 | 12 | 0.190 |
Why?
| DNA, Bacterial | 2 | 2018 | 324 | 0.190 |
Why?
| Weight Reduction Programs | 1 | 2021 | 95 | 0.180 |
Why?
| Fasting | 1 | 2021 | 266 | 0.180 |
Why?
| Cohort Studies | 6 | 2020 | 5294 | 0.180 |
Why?
| Adult | 9 | 2023 | 32385 | 0.180 |
Why?
| Western World | 1 | 2019 | 6 | 0.180 |
Why?
| Atherosclerosis | 1 | 2023 | 354 | 0.180 |
Why?
| Precision Medicine | 1 | 2023 | 371 | 0.180 |
Why?
| Adolescent | 5 | 2021 | 18948 | 0.180 |
Why?
| Intra-Aortic Balloon Pumping | 1 | 2019 | 22 | 0.170 |
Why?
| Fluid Therapy | 1 | 2020 | 149 | 0.170 |
Why?
| Perioperative Care | 1 | 2020 | 136 | 0.170 |
Why?
| Proportional Hazards Models | 6 | 2018 | 1184 | 0.170 |
Why?
| Cardiac Catheterization | 3 | 2018 | 577 | 0.170 |
Why?
| Prospective Studies | 3 | 2021 | 6704 | 0.160 |
Why?
| Epidemiology | 1 | 2018 | 16 | 0.160 |
Why?
| Young Adult | 5 | 2021 | 11094 | 0.160 |
Why?
| Documentation | 1 | 2020 | 180 | 0.160 |
Why?
| Practice Patterns, Physicians' | 2 | 2017 | 1267 | 0.160 |
Why?
| Drug Users | 1 | 2018 | 39 | 0.160 |
Why?
| Genome-Wide Association Study | 2 | 2023 | 1376 | 0.160 |
Why?
| Clostridium Infections | 1 | 2018 | 61 | 0.160 |
Why?
| Stress Disorders, Post-Traumatic | 2 | 2017 | 770 | 0.160 |
Why?
| Streptococcus | 1 | 2017 | 25 | 0.160 |
Why?
| Genes, rRNA | 1 | 2017 | 42 | 0.160 |
Why?
| Vancomycin | 1 | 2018 | 81 | 0.150 |
Why?
| Homeostasis | 1 | 2021 | 596 | 0.150 |
Why?
| Atherectomy, Coronary | 1 | 2017 | 11 | 0.150 |
Why?
| Behavior, Addictive | 1 | 2018 | 79 | 0.150 |
Why?
| History, 21st Century | 1 | 2018 | 177 | 0.150 |
Why?
| Coronary Stenosis | 1 | 2017 | 44 | 0.150 |
Why?
| Contrast Media | 1 | 2020 | 387 | 0.150 |
Why?
| Coronary Occlusion | 1 | 2017 | 20 | 0.150 |
Why?
| Dysbiosis | 1 | 2018 | 148 | 0.150 |
Why?
| Cocaine-Related Disorders | 1 | 2018 | 110 | 0.150 |
Why?
| Blood Transfusion | 2 | 2017 | 312 | 0.150 |
Why?
| Infant, Newborn | 2 | 2018 | 5430 | 0.150 |
Why?
| Data Collection | 1 | 2020 | 667 | 0.150 |
Why?
| Psychological Trauma | 1 | 2017 | 55 | 0.150 |
Why?
| Population Surveillance | 1 | 2020 | 439 | 0.140 |
Why?
| Social Determinants of Health | 1 | 2018 | 141 | 0.140 |
Why?
| Program Evaluation | 3 | 2017 | 880 | 0.140 |
Why?
| Career Choice | 1 | 2018 | 206 | 0.140 |
Why?
| Comorbidity | 2 | 2018 | 1600 | 0.140 |
Why?
| Glucose | 1 | 2021 | 968 | 0.140 |
Why?
| Treatment Outcome | 10 | 2019 | 9692 | 0.140 |
Why?
| Adipose Tissue | 1 | 2020 | 616 | 0.140 |
Why?
| Hemorrhage | 2 | 2017 | 663 | 0.140 |
Why?
| Femoral Artery | 1 | 2017 | 182 | 0.130 |
Why?
| Algorithms | 2 | 2020 | 1593 | 0.130 |
Why?
| Medication Errors | 1 | 2016 | 98 | 0.130 |
Why?
| Vascular Calcification | 1 | 2017 | 124 | 0.130 |
Why?
| Research Report | 1 | 2016 | 83 | 0.130 |
Why?
| Genetic Predisposition to Disease | 2 | 2021 | 2359 | 0.130 |
Why?
| Diabetes Mellitus | 1 | 2023 | 985 | 0.130 |
Why?
| Prognosis | 2 | 2021 | 3563 | 0.130 |
Why?
| Delivery of Health Care, Integrated | 1 | 2017 | 247 | 0.120 |
Why?
| Saphenous Vein | 1 | 2014 | 36 | 0.120 |
Why?
| Infant | 2 | 2018 | 8523 | 0.120 |
Why?
| Myocardial Ischemia | 1 | 2016 | 267 | 0.120 |
Why?
| Arterial Occlusive Diseases | 1 | 2014 | 81 | 0.120 |
Why?
| Drug-Eluting Stents | 1 | 2014 | 79 | 0.120 |
Why?
| Antimicrobial Stewardship | 1 | 2016 | 95 | 0.120 |
Why?
| Stents | 2 | 2014 | 491 | 0.120 |
Why?
| Child, Preschool | 2 | 2018 | 9755 | 0.120 |
Why?
| Premature Birth | 1 | 2017 | 304 | 0.120 |
Why?
| Patient Selection | 2 | 2016 | 717 | 0.110 |
Why?
| Overweight | 1 | 2017 | 516 | 0.110 |
Why?
| Renal Dialysis | 1 | 2017 | 395 | 0.110 |
Why?
| Retrospective Studies | 10 | 2020 | 13433 | 0.110 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2016 | 425 | 0.110 |
Why?
| Databases, Factual | 4 | 2019 | 1287 | 0.110 |
Why?
| Anti-Bacterial Agents | 2 | 2020 | 1562 | 0.110 |
Why?
| Blood Glucose | 1 | 2021 | 1957 | 0.100 |
Why?
| Healthcare Disparities | 1 | 2017 | 494 | 0.100 |
Why?
| Chi-Square Distribution | 3 | 2018 | 551 | 0.100 |
Why?
| Kidney Failure, Chronic | 1 | 2017 | 519 | 0.100 |
Why?
| Sex Factors | 1 | 2017 | 1860 | 0.100 |
Why?
| Insulin | 1 | 2021 | 2180 | 0.100 |
Why?
| Coronary Disease | 1 | 2013 | 372 | 0.100 |
Why?
| Military Personnel | 1 | 2018 | 584 | 0.100 |
Why?
| Hospitals, Veterans | 3 | 2018 | 260 | 0.100 |
Why?
| Biomarkers | 1 | 2021 | 3662 | 0.090 |
Why?
| Magnetic Resonance Imaging | 2 | 2021 | 3264 | 0.090 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 4734 | 0.090 |
Why?
| Pediatrics | 1 | 2018 | 1009 | 0.090 |
Why?
| Prevalence | 4 | 2018 | 2442 | 0.090 |
Why?
| Aged, 80 and over | 5 | 2020 | 6845 | 0.090 |
Why?
| Hospitalization | 2 | 2016 | 1914 | 0.090 |
Why?
| Stroke | 1 | 2018 | 1090 | 0.090 |
Why?
| Colorado | 1 | 2018 | 4325 | 0.080 |
Why?
| Health Services Accessibility | 1 | 2014 | 813 | 0.080 |
Why?
| Surveys and Questionnaires | 1 | 2018 | 4882 | 0.070 |
Why?
| Kaplan-Meier Estimate | 2 | 2018 | 884 | 0.060 |
Why?
| Hypertension, Pulmonary | 1 | 2016 | 1900 | 0.060 |
Why?
| Longitudinal Studies | 2 | 2021 | 2599 | 0.060 |
Why?
| Immunoglobulins | 2 | 1974 | 166 | 0.060 |
Why?
| Logistic Models | 2 | 2017 | 1995 | 0.050 |
Why?
| Diet Surveys | 1 | 2021 | 86 | 0.050 |
Why?
| Consensus | 1 | 2023 | 554 | 0.050 |
Why?
| Lipase | 1 | 2021 | 70 | 0.050 |
Why?
| Forehead | 1 | 2020 | 6 | 0.050 |
Why?
| Genetic Markers | 1 | 2021 | 358 | 0.050 |
Why?
| Free Radical Scavengers | 1 | 2020 | 90 | 0.050 |
Why?
| Patient Readmission | 2 | 2017 | 691 | 0.050 |
Why?
| Mouth | 1 | 2020 | 81 | 0.050 |
Why?
| Sodium Bicarbonate | 1 | 2020 | 51 | 0.050 |
Why?
| Datasets as Topic | 1 | 2020 | 110 | 0.040 |
Why?
| Gene-Environment Interaction | 1 | 2021 | 206 | 0.040 |
Why?
| Quality Improvement | 2 | 2018 | 1004 | 0.040 |
Why?
| Critical Pathways | 1 | 2020 | 78 | 0.040 |
Why?
| Clinical Laboratory Techniques | 1 | 2020 | 93 | 0.040 |
Why?
| Acetylcysteine | 1 | 2020 | 150 | 0.040 |
Why?
| Oceania | 1 | 2018 | 2 | 0.040 |
Why?
| Evidence-Based Medicine | 1 | 2023 | 731 | 0.040 |
Why?
| Child Behavior | 1 | 2021 | 238 | 0.040 |
Why?
| Intraoperative Period | 1 | 2019 | 56 | 0.040 |
Why?
| Linear Models | 1 | 2021 | 854 | 0.040 |
Why?
| Skin | 1 | 2023 | 694 | 0.040 |
Why?
| North America | 1 | 2018 | 271 | 0.040 |
Why?
| Europe | 1 | 2018 | 369 | 0.040 |
Why?
| Echocardiography, Stress | 1 | 2017 | 27 | 0.040 |
Why?
| Drug Prescriptions | 1 | 2020 | 271 | 0.040 |
Why?
| Residence Characteristics | 1 | 2020 | 313 | 0.040 |
Why?
| Surgical Wound Infection | 1 | 2020 | 251 | 0.040 |
Why?
| Myeloma Proteins | 2 | 1974 | 7 | 0.040 |
Why?
| Punctures | 1 | 2017 | 39 | 0.040 |
Why?
| Feasibility Studies | 1 | 2020 | 780 | 0.040 |
Why?
| Self Report | 1 | 2021 | 730 | 0.040 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 194 | 0.040 |
Why?
| Transfusion Reaction | 1 | 2017 | 77 | 0.040 |
Why?
| Adsorption | 2 | 1974 | 130 | 0.040 |
Why?
| Glomerular Filtration Rate | 1 | 2020 | 697 | 0.040 |
Why?
| RNA, Bacterial | 1 | 2017 | 180 | 0.040 |
Why?
| Contraindications | 1 | 2016 | 102 | 0.040 |
Why?
| Drug Labeling | 1 | 2016 | 48 | 0.040 |
Why?
| Adolescent Behavior | 1 | 2021 | 495 | 0.030 |
Why?
| Drug Utilization Review | 1 | 2016 | 65 | 0.030 |
Why?
| Pregnancy Outcome | 1 | 2018 | 364 | 0.030 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2016 | 74 | 0.030 |
Why?
| Health Behavior | 1 | 2021 | 731 | 0.030 |
Why?
| Vasodilator Agents | 1 | 2017 | 339 | 0.030 |
Why?
| Risk-Taking | 1 | 2018 | 334 | 0.030 |
Why?
| Device Removal | 1 | 2016 | 127 | 0.030 |
Why?
| Membrane Proteins | 1 | 2021 | 1093 | 0.030 |
Why?
| Bioprosthesis | 1 | 2014 | 37 | 0.030 |
Why?
| Antibodies, Anti-Idiotypic | 1 | 1974 | 72 | 0.030 |
Why?
| Angina, Unstable | 1 | 2014 | 82 | 0.030 |
Why?
| Survival Rate | 1 | 2019 | 1810 | 0.030 |
Why?
| Odds Ratio | 1 | 2017 | 1043 | 0.030 |
Why?
| Metals | 1 | 2014 | 116 | 0.030 |
Why?
| Mortality | 1 | 2016 | 317 | 0.030 |
Why?
| Pregnancy Complications | 1 | 2018 | 462 | 0.030 |
Why?
| Health Promotion | 1 | 2020 | 707 | 0.030 |
Why?
| Mental Health | 1 | 2018 | 571 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2017 | 1531 | 0.030 |
Why?
| Patient Safety | 1 | 2016 | 302 | 0.030 |
Why?
| Pilot Projects | 1 | 2017 | 1477 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2017 | 1947 | 0.030 |
Why?
| Sex Characteristics | 1 | 2017 | 690 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2020 | 1519 | 0.030 |
Why?
| Antibodies | 1 | 1973 | 400 | 0.020 |
Why?
| Chronic Disease | 1 | 2017 | 1645 | 0.020 |
Why?
| Peptides | 1 | 2016 | 893 | 0.020 |
Why?
| Disease Progression | 1 | 2017 | 2546 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 2016 | 1306 | 0.020 |
Why?
| Postoperative Complications | 1 | 2020 | 2301 | 0.020 |
Why?
| Medicare | 1 | 2013 | 767 | 0.020 |
Why?
| Heart Failure | 1 | 2020 | 2114 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2013 | 4768 | 0.020 |
Why?
| Immune Sera | 2 | 1974 | 83 | 0.020 |
Why?
| Antibody Specificity | 2 | 1974 | 190 | 0.010 |
Why?
| Rabbits | 2 | 1974 | 808 | 0.010 |
Why?
| Immunoglobulin M | 2 | 1974 | 288 | 0.010 |
Why?
| Immunoglobulin G | 2 | 1974 | 804 | 0.010 |
Why?
| Immunodiffusion | 1 | 1974 | 10 | 0.010 |
Why?
| Antibody-Producing Cells | 1 | 1974 | 33 | 0.010 |
Why?
| Chromatography, Gel | 1 | 1974 | 129 | 0.010 |
Why?
| Immunoglobulin Heavy Chains | 1 | 1974 | 75 | 0.010 |
Why?
| Globulins | 1 | 1973 | 1 | 0.010 |
Why?
| Immunoelectrophoresis | 1 | 1973 | 6 | 0.010 |
Why?
| Chloroform | 1 | 1973 | 4 | 0.010 |
Why?
| Microsomes | 1 | 1973 | 25 | 0.010 |
Why?
| Species Specificity | 1 | 1974 | 578 | 0.010 |
Why?
| Antibody Formation | 1 | 1974 | 285 | 0.010 |
Why?
| Solubility | 1 | 1973 | 240 | 0.010 |
Why?
| Animals, Newborn | 1 | 1974 | 825 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1974 | 1245 | 0.010 |
Why?
| Ethanol | 1 | 1973 | 584 | 0.010 |
Why?
| Cell Differentiation | 1 | 1974 | 1805 | 0.000 |
Why?
| Animals | 2 | 1974 | 34133 | 0.000 |
Why?
| Mice | 1 | 1974 | 15888 | 0.000 |
Why?
|
|
Stanislawski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|